retatrutide triple agonist phase 2 nejm 2023 obesity results just delivered the first top-line 3 for a in — and the findings from TRIUMPH-4 are striking👇 Today, we shared new data

These facials can help improve skin tone, reduce dullness, and give a visible glow

The key findings were: Tirzepatide met the primary goal of cardiovascular non-inferiority , confirming it is at least as safe for the heart as dulaglutide It did not quite meet statistical superiority over dulaglutide for MACE, although results trended in favour of tirzepatide Tirzepatide produced significantly greater reductions in HbA1c and body weight than dulaglutide Importantly, because SURPASS-CVOT used an active comparator with established cardiovascular benefit rather than a placebo, demonstrating superiority was inherently more difficult than in earlier placebo-controlled GLP-1 outcome trials

MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis

As more people take compounded forms of semaglutide drugs and experience injuries, more lawsuits are expected to be filed

Choose source: calc_source A1C to eAG calc_source eAG to A1C Unit to calculate from To: calc_target mg/dL calc_target mmol/L To view or add a comment, sign in ADA is recommending the use of a new term in diabetes management, estimated average glucose, or eAG